programmed cell death 1 ligand 1 gene mutation
Showing 1 - 1 of 1
Biliary Tract Cancer, Programmed Cell Death 1 Ligand 1 Gene Mutation, Targeted Molecular Therapy Trial in Beijing (Camrelizumab,
Not yet recruiting
- Biliary Tract Cancer
- +3 more
- Camrelizumab
- +2 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Jan 20, 2021